Literature DB >> 17727304

A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Peter A G M De Smet1, Wilma Denneboom, Cees Kramers, Richard Grol.   

Abstract

Regular performance of medication reviews is prominent among methods that have been advocated to reduce the extent and seriousness of drug-related problems, such as adverse drug reactions, drug-disease interactions, drug-drug interactions, drug ineffectiveness and cost ineffectiveness. Several screening tools have been developed to guide practising healthcare professionals and researchers in reviewing the medication patterns of elderly patients; however, each of these tools has its own limitations. This review discusses a wide range of general prescription-, treatment- and patient-related issues that should be taken into account when reviewing medication patterns by implicit screening. These include generic and therapeutic substitution; potentially superfluous or inappropriate medications; potentially inappropriate dosages or duration of treatment; drug-disease and drug-drug interactions; under-treatment; making use of laboratory test results; patient adherence, experiences and habits; appropriate dosage forms and packaging. A broad selection of specific examples and references that can be used as a basis for explicit screening of medication patterns in outpatients is also offered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727304     DOI: 10.2165/00002512-200724090-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  325 in total

Review 1.  [Expectorants. Help for acute cold bronchitis?].

Authors:  Bettina Polk
Journal:  Med Monatsschr Pharm       Date:  2002-11

2.  Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated?

Authors:  Calvin M Kunin
Journal:  Arch Intern Med       Date:  2004 Aug 9-23

3.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

Review 4.  Pharmacogenetics in health-care practice.

Authors:  der Zee Anke-Hilse Maitland-van; Olaf H Klungel; Anthonius de Boer
Journal:  Pharm World Sci       Date:  2004-10

5.  Nine key questions to address polypharmacy in the elderly.

Authors:  Reamer L Bushardt; Kelly W Jones
Journal:  JAAPA       Date:  2005-05

6.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

Review 7.  Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence.

Authors:  Rachel A Elliott; Nick Barber; Rob Horne
Journal:  Ann Pharmacother       Date:  2005-01-18       Impact factor: 3.154

Review 8.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

9.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

10.  A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.

Authors:  J T Hanlon; M Weinberger; G P Samsa; K E Schmader; K M Uttech; I K Lewis; P A Cowper; P B Landsman; H J Cohen; J R Feussner
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

View more
  17 in total

1.  Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review).

Authors:  Sarah Snyder Lee; Ann K Schwemm; Jeffrey Reist; Matthew Cantrell; Michael Andreski; William R Doucette; Elizabeth A Chrischilles; Karen B Farris
Journal:  Am J Pharm Educ       Date:  2009-05-27       Impact factor: 2.047

2.  Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands.

Authors:  Willemijn L Eppenga; Hieronymus J Derijks; Jean M H Conemans; Walter A J J Hermens; Michel Wensing; Peter A G M De Smet
Journal:  J Am Med Inform Assoc       Date:  2011-09-02       Impact factor: 4.497

3.  Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions.

Authors:  O Alagoz; D Durham; K Kasirajan
Journal:  Pharmacogenomics J       Date:  2015-05-19       Impact factor: 3.550

4.  Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force.

Authors:  Margaretha F Warlé-van Herwaarden; Cees Kramers; Miriam C Sturkenboom; Patricia M L A van den Bemt; Peter A G M De Smet
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

5.  Potentially inappropriate prescribing and cost outcomes for older people: a national population study.

Authors:  Caitriona Cahir; Tom Fahey; Mary Teeling; Conor Teljeur; John Feely; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 6.  Medication errors: problems and recommendations from a consensus meeting.

Authors:  Abha Agrawal; Jeffrey K Aronson; Nicky Britten; Robin E Ferner; Peter A de Smet; Daniela Fialová; Richard J Fitzgerald; Robert Likić; Simon R Maxwell; Ronald H Meyboom; Pietro Minuz; Graziano Onder; Michael Schachter; Giampaolo Velo
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

7.  Medication errors in elderly people: contributing factors and future perspectives.

Authors:  Daniela Fialová; Graziano Onder
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

8.  The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients.

Authors:  Fatma Karapinar-Carkit; Sander D Borgsteede; Jan Zoer; Carl Siegert; Maurits van Tulder; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  BMC Health Serv Res       Date:  2010-02-16       Impact factor: 2.655

Review 9.  Deprescribing of non-antiretroviral therapy in HIV-infected patients.

Authors:  José-Ramón Blanco; Ramón Morillo; Vicente Abril; Ismael Escobar; Enrique Bernal; Carlos Folguera; Fátima Brañas; Mercedes Gimeno; Olatz Ibarra; José-Antonio Iribarren; Alicia Lázaro; Ana Mariño; María-Teresa Martín; Esteban Martinez; Luis Ortega; Julian Olalla; Aguas Robustillo; Matilde Sanchez-Conde; Miguel-Angel Rodriguez; Javier de la Torre; Javier Sanchez-Rubio; Montse Tuset
Journal:  Eur J Clin Pharmacol       Date:  2019-12-21       Impact factor: 2.953

10.  Effectiveness of medication review on the number of drug-related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial.

Authors:  Victor Johan Bernard Huiskes; Cornelia Helena Maria van den Ende; Martine Kruijtbosch; Hendrik Tinus Ensing; Marieke Meijs; Veronique Maria Mathea Meijs; David Marinus Burger; Bartholomeus Johannes Fredericus van den Bemt
Journal:  Br J Clin Pharmacol       Date:  2019-12-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.